Varenicline for smoking cessation
86 results
1 - 86
Varenicline effective for smoking cessation- Varenicline (Chantix) effective for smoking cessation
Varenicline for smoking cessation - Varenicline for smoking cessation in individuals with schizophrenia
- Varenicline, bupropion, nicotine replacement all effective for smoking cessation
- Cytisine unable to demonstrate noninferiority to varenicline, but is still an option for smoking cessation
- No benefit to varenicline beyond 12 weeks or combined with nicotine replacement therapy for smoking cessation
Nicotine receptor partial agonists for smoking cessation: Cochrane systematic review- Smoking cessation
- Counseling is equal to varenicline to help adolescents quit smoking
- Varenicline plus nicotine replacement therapy more effective than varenicline alone
- Maintenance treatment with varenicline improves smoking cessation in patients with schizophrenia and bipolar disorder
- Interventions for smoking cessation and reduction in individuals with schizophrenia New search for studies and content updated (no change to conclusions)
- Varenicline similar in effectiveness to nicotine patch
- Smoking cessation medication for preventing weight gain after cessation
- Combo treatment better than varenicline alone in male and highly dependent smokers
- Varenicline (Chantix) not associated with increased CV events
- Varenicline effective for smokers preferring to "cut down" rather than quit "cold turkey"
- Varenicline and bupropion and suicidal behaviour
- Interventions for preoperative smoking cessation: Cochrane systematic review
- Varenicline plus bupropion SR no better than varenicline alone for tobacco cessation
- American Thoracic Society guideline for initiating medications for smoking cessation
- Interventions for smoking cessation in hospitalised patients: Cochrane systematic review
- Interventions for smoking cessation in patients with psyhiatric disorders
- Antidepressants for smoking cessation Edited (no change to conclusions)
- Antidepressants for smoking cessation
- Varenicline increases smokeless tobacco cessation
- Varenicline, bupropion may not increase risk of cardiovascular events
- Pharmacological interventions for smoking cessation: an overview and network meta‐analysis Edited (no change to conclusions)
- Pharmacological interventions for promoting smoking cessation during pregnancy New search for studies and content updated (no change to conclusions)
- Smoking cessation for people with chronic obstructive pulmonary disease
- Smoking cessation interventions for smokers with current or past depression: Cochrane systematic review
- USPSTF 2021 updates on effective interventions for tobacco smoking cessation in adults, including pregnant persons
- Interventions for smoking cessation in Indigenous populations: Cochrane systematic review
- Relapse prevention interventions for smoking cessation
- Varenicline increases risk of adverse CV events
- Smoking reduction interventions for smoking cessation New
- Training health professionals in smoking cessation Edited (no change to conclusions)
- Nicotine replacement therapy for smoking cessation
- Relapse prevention interventions for smoking cessation New search for studies and content updated (no change to conclusions)
- Inpatient smoking cessation strategy promising, but effects aren't long lasting
- Pharmacological interventions for promoting smoking cessation during pregnancy
- Interventions for smokeless tobacco use cessation Edited (no change to conclusions)
- Cytisine is inexpensive, safe, and modestly effective for smoking cessation
- Interventions for preventing weight gain after smoking cessation Edited (no change to conclusions)
- Combined nicotine replacement therapy for smoking cessation
- Interventions to reduce harm from continued tobacco use Edited (no change to conclusions)
- Combined pharmacotherapy and behavioural interventions for smoking cessation: Cochrane systematic review
- Cytisine more effective than nicotine for smoking cessation, but with more adverse effects
- Postdischarge tobacco cessation intervention results in higher quit rates for hospitalized smokers
- Smoking cessation for people with chronic obstructive pulmonary disease Edited (no change to conclusions)
- Schizophrenia
- Additional behavioural support as an adjunct to pharmacotherapy for smoking cessation New search for studies and content updated (no change to conclusions)
- Interventions for recruiting smokers into cessation programmes
- Interventions to increase adherence to medications for tobacco dependence New search for studies and content updated (no change to conclusions)
- Nicotine replacement therapy to reduce continued tobacco use
- Electronic cigarettes for smoking cessation Edited (no change to conclusions)